Key Takeaways of CDDF Webinar : “Transformation of future clinical trials using AI-enhanced imaging biomarkers”
The Cancer Drug Development Forum (CDDF) is pleased to present key takeaways of our live webinar series on “AI and Big Data in Cancer Drug Development.” This series is designed to explore the transformative impact of artificial intelligence and big data on oncology....
NEW PUBLICATION – WHITE PAPER: Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action.
The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper – “Overcoming the Barriers to Treatment of Rare Cancer”- has been published, following its “Innovation and Access in Rare Cancers” hybrid workshop held on 23-24 September 2024...
NEW PUBLICATION – WHITE PAPER: Dose Optimization in Cancer Drug Development – Review and Outcome of a Multi-Stakeholder Workshop
The Cancer Drug Development Forum (CDDF) is pleased to announce the release of a White Paper developed following the multi-stakeholder workshop “Dose Optimization in Cancer Drug Development,” held on 3–4 April 2023 in Amsterdam, the Netherlands, as a hybrid event....
Key Takeaways CDDF Live Webinar series – Bayesian Framework: Bayesian Approaches in Oncology Drug Development: Introduction and Motivations
The Cancer Drug Development Forum (CDDF) held a live webinar on “Bayesian Approaches in Oncology Drug Development: Introduction and Motivations” on 14 May at 17:00 CET. Conducted by Purvi Prajapati (Eli Lilly) and Natasha Mulhemann (Cytel). The lectures were followed...